Opzelura (ruxolitinib) topical cream

ruxolitinib · Incyte

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opzelura (ruxolitinib) topical cream, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment [Phase 2]